Health Care & Life Sciences » Hospitals, Physicians & Pharmacies » HIV/AIDS worldwide | Top AIDS drugs by revenue worldwide 2009-2017

Top AIDS drugs worldwide based on revenue 2014-2017

Selected top AIDS drugs worldwide based on revenue from 2014 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays some of the leading AIDS drugs worldwide based on revenue from 2014 to 2017. In 2014, GlaxoSmithKline's Epzicom generated a revenue of 1.19 billion USD. However, this revenue decreased to some 316 million USD in 2017.

Triumeq, GSK 1082 2134 3320
Truvada, Gilead 3340 3459 3566 3134
Tivicay, GSK 872 1172 1894
Prezista, J&J 1831 1810 1851 1821
Atripla, Gilead 3470 3134 2605 1806
Isentress, Merck & Co. 1673 1511 1387 1204
Stribild, Gilead 1197 1825 1914 1053
Viread, Gilead 1058 1108 1186 1046
Complera/Eviplera, Gilead 1228 1427 1457 966
Sustiva, BMS 1444 1252 1065 729
Epzicom, GSK 1193 1035 699 316

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.